The Temperature Wars: Why the Degree to Which You Heat Nicotine Matters More Than You Think

At 900°C, tobacco burns. The combustion produces a chemical apocalypse: over 7,000 compounds, including at least 70 known human carcinogens, generated by the thermal decomposition of tobacco biomass. At 300°C, tobacco doesn't burn—it heats. The aerosol it produces contains dramatically fewer toxicants—an estimated 90-95% reduction compared to cigarette smoke. At 37°C, body temperature, nothing is heated at all—nicotine is absorbed through the oral mucosa (pouches, snus, gum) or the skin (patches), with no thermal degradation products whatsoever. **The temperature at which nicotine is delivered is not a technical detail. It's the primary determinant of health risk—and the temperature wars are the most important scientific debate in nicotine policy.**

**The temperature-risk relationship is remarkably consistent.** Combustion (cigarettes): catastrophic risk—cancer, cardiovascular disease, COPD, premature death. High-temperature vaporization (some vaping devices operating above optimal temperature): substantially reduced risk compared to combustion, but with measurable levels of thermal degradation products (formaldehyde, acetaldehyde) that raise concerns. Low-temperature vaporization (optimized devices): further reduced risk, with thermal degradation products near or below detection limits. No heating (pouches, snus, NRT): minimal risk—no combustion products, no thermal degradation, only the effects of nicotine itself (cardiovascular stimulation, potential reproductive effects). **The policy framework that treats all non-combustible products as equivalent—subjecting them to the same restrictions, the same taxes, the same communication—ignores the temperature dimension that is the primary determinant of their health impact.**

**The regulatory implication is that temperature should be a dimension of product evaluation and classification.** A product that operates at 200°C should be regulated differently from a product that operates at 300°C—because the thermal degradation profile is different, and the health risk is different. A product with temperature control—a feature that prevents the device from exceeding a user-set limit—should be regulated favorably compared to a product without temperature control. **The temperature dimension provides an evidence-based framework for distinguishing between products that are all 'non-combustible' but that have very different risk profiles. The regulatory system that ignores temperature is missing the most important variable in nicotine product risk.**

**💬 Did you know that the temperature at which nicotine is heated is the primary determinant of health risk—and that the difference between 200°C and 900°C is the difference between 'dramatically safer than smoking' and 'catastrophic'? Should regulators use temperature to distinguish between nicotine products?**